2019 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
Implantable devices
Drug must be extremely potent, as totalmass dose to be loaded is small • E.g., etonogestrel implant .06mg/day
Chua, CROI 2017 Durham, CROI 2018 Hendrix,MTN 2017
Slide56of58FromHScott,MD,MPHatNewOrleans,LA,December4-7, 2019,RyanWhiteHIV/AIDS ProgramCLINICAL CONFERENCE, IAS USA.
Formulation PK profiles compared
Slide57of58FromHScott,MD,MPHatNewOrleans,LA,December4-7, 2019,RyanWhiteHIV/AIDS ProgramCLINICAL CONFERENCE, IAS USA.
Question-and-Answer Period
FromHScott,MD,MPH atNewOrleans,LA,December4-7,2019,RyanWhiteHIV/AIDS ProgramCLINICAL CONFERENCE, IAS USA.
Made with FlippingBook flipbook maker